Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A phase II study of depsipeptide (Dep) in patients (pts) with metastatic renal cell cancer (RCC).
Enhanced Catecholamine Flux and Impaired Carbonyl Metabolism Disrupt Cardiac Mitochondrial Oxidative Phosphorylation in Diabetes Patients.
Genomic history of the Sardinian population.
Single Umbilical Artery
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase II study of depsipeptide (Dep) in patients (pts) with metastatic renal cell cancer (RCC).
A phase II study of depsipeptide (Dep) in patients (pts) with metastatic renal cell cancer (RCC). J Clin Oncol. 2005 Jun; 23(16_suppl):4669.
View in:
PubMed